Studies on the mechanisms of C9 activation and of C9 inactivation by the regulatory protein(MACIF)
Studies on the mechanisms of C9 activation and of C9 inactivation by the regulatory protein(MACIF)
批准号:
03671118
负责人:
HATANAKA Michiyo
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
补体系统由20多种血清蛋白组成,在宿主防御中发挥重要作用。补体成分C9通过插入含有预先形成的C9受体C5b-8的膜,在补体级联的最后一步发挥作用。C9与C5b-8复合体相互作用后发生剧烈的构象变化。虽然已经证明了整个初级结构,但结构和功能之间的关系还没有完全理解。在这项研究中,我们试图用抗C9的单抗和化学修饰试剂DTT来阐明C9激活的机制。事实证明,1.C5b-8的结合涉及C9的两个独立的环状结构。C9的功能结构域由二硫键支撑。二硫键的不同和不同的结构域与C5b-8的结合、溶血活性和C9的自聚有关,补体功能仅针对非自体膜,而自体膜上不发生激活。补体调节蛋白(DAF、Macif、MCP、CR1)在自我决定和非自我决定中发挥重要作用。我们通过将分离的蛋白结合到影响这些蛋白的PNH红细胞上来评估DAF和Macif的功能。
英文摘要
The complement system consist of more than 20 serum proteins and play an important role in host defense. Complement component C9 exerts at the final step of complement cascade by inserting into membranes which contain preformed C9 acceptor, C5b-8. C9 proceeds drastic conformational changes upon interaction with C5b-8 complex. Although the entire primary structure has already been demonstrated, the structual and function relationship is not fully ubderstood. In this research, we intended to clarify the mechanisms of C9 activation by using monoclonal antibodies to C9 and also with chemical modification reagent, DTT. It has been demonstrated that1. Two seperate epoitipes of C9 are involved in C5b-8 binding.2. Functional domains of C9 are supported by disulfide bridges.3. Different and distinct domains of disulfide bridges are implicated in binding to C5b-8, hemolytic activity, and self-polymerization of C9.Complement functions are targeted only on non-self membranes, and activation does not occur on self membranes. Complement regulating proteins (DAF, MACIF, MCP, CR1) have now been demonstrated to play the crucial roles in self- and non-self determination. We have assesed the function of DAF and MACIF by inccorporating the isolated proteins to PNH erythrocytes which deffect these proteins.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
宮川 周士: "Test for ability of decay-accelerating factor(DAF,CD55)and CD59 to alleviate complement-mediated damage of xeno-erythrocytes" Scandinavian Journal of Immunology.
Shuji Miyakawa:“测试衰变加速因子(DAF、CD55)和 CD59 减轻补体介导的异种红细胞损伤的能力”斯堪的纳维亚免疫学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Michiyo Hatanaka: "Analysis of C5b-8 bindig sites in C9 molecules using monoclonal antibodies : participation of two seperate epitopes of C9 in C5b-8 binding" Molecular Immunology. 29. 911-916 (1992)
Michiyo Hatanaka:“使用单克隆抗体分析 C9 分子中的 C5b-8 结合位点:C9 的两个单独表位参与 C5b-8 结合”分子免疫学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mechanisms involved in GPI-anchored-protein signaling dimer formation
-
批准号:10672190
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:HATANAKA Michiyo
-
依托单位:
The Signal Transduction Mechanisms of a GPI-anchored Complement Regulatory Protein, CD59.
-
批准号:08672654
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:HATANAKA Michiyo
-
依托单位:
Mechanisms involved in loss of PI-anchored proteins (DAF and CD59) in human leukemia cell lines.
-
批准号:05671933
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:HATANAKA Michiyo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
内源酶介导豌豆浆LA/ALA磷脂形成C6/C9醛/醇异味的分子机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:毕爽
-
依托单位:
高静压介导下甜瓜果胶结构解聚对C6/C9醛醇类香气成分稳态化影响的分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:吴继红
-
依托单位:
紫杉醇合成中催化C1和C9位羟化反应的P450羟化酶挖掘及催化特性研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:付春华
-
依托单位:
补体C9基因缺陷对B6狼疮型小鼠自身免疫病发病的促进作用及机制研究
-
批准号:81873883
-
项目类别:面上项目
-
资助金额:81.0万元
-
批准年份:2018
-
负责人:梁淑娟
-
依托单位:
黄瓜脂氧合酶基因CsLOX02和CsLOX08在C9醛类香气合成中的功能解析
-
批准号:31572143
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2015
-
负责人:陈书霞
-
依托单位:
超高压处理对哈密瓜汁中C6、C9 醛、醇形成机理研究
-
批准号:31560461
-
项目类别:地区科学基金项目
-
资助金额:40.0万元
-
批准年份:2015
-
负责人:陈计峦
-
依托单位:
纳米结构催化电极电解固定CO2为C9以上新有机物的研究
-
批准号:20476001
-
项目类别:面上项目
-
资助金额:19.0万元
-
批准年份:2004
-
负责人:褚道葆
-
依托单位:
c9,t11-CLA影响肿瘤细胞亚油酸代谢的机制研究
-
批准号:30271129
-
项目类别:面上项目
-
资助金额:23.0万元
-
批准年份:2002
-
负责人:陈炳卿
-
依托单位: